Goloudina AR - Search Results

1

Inhibition of the DNA damage response phosphatase PPM1D reprograms neutrophils to enhance anti-tumor immune responses.

Uyanik B, Goloudina AR, Akbarali A, Grigorash BB, Petukhov AV, Singhal S, Eruslanov E, Chaloyard J, Lagorgette L, Hadi T, Baidyuk EV, Sakai H, Tessarollo L, Ryffel B, Mazur SJ, Lirussi F, Garrido C, Appella E, Demidov ON. Uyanik B, et al. Among authors: goloudina ar. Nat Commun. 2021 Jun 15;12(1):3622. doi: 10.1038/s41467-021-23330-6. Nat Commun. 2021. PMID: 34131120 Free PMC article.

2

Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy.

Clausse V, Goloudina AR, Uyanik B, Kochetkova EY, Richaud S, Fedorova OA, Hammann A, Bardou M, Barlev NA, Garrido C, Demidov ON. Clausse V, et al. Among authors: goloudina ar. Cell Death Dis. 2016 Apr 14;7(4):e2195. doi: 10.1038/cddis.2016.96. Cell Death Dis. 2016. PMID: 27077811 Free PMC article.

3

DNA damage-induced phosphatase Wip1 in regulation of hematopoiesis, immune system and inflammation.

Uyanik B, Grigorash BB, Goloudina AR, Demidov ON. Uyanik B, et al. Among authors: goloudina ar. Cell Death Discov. 2017 Apr 3;3:17018. doi: 10.1038/cddiscovery.2017.18. eCollection 2017. Cell Death Discov. 2017. PMID: 28417018 Free PMC article. Review.

4

Wip1 promotes RUNX2-dependent apoptosis in p53-negative tumors and protects normal tissues during treatment with anticancer agents.

Goloudina AR, Tanoue K, Hammann A, Fourmaux E, Le Guezennec X, Bulavin DV, Mazur SJ, Appella E, Garrido C, Demidov ON. Goloudina AR, et al. Proc Natl Acad Sci U S A. 2012 Jan 10;109(2):E68-75. doi: 10.1073/pnas.1107017108. Epub 2011 Nov 7. Proc Natl Acad Sci U S A. 2012. PMID: 22065775 Free PMC article.

5

Wip1 sensitizes p53-negative tumors to apoptosis by regulating the Bax/Bcl-xL ratio.

Goloudina AR, Mazur SJ, Appella E, Garrido C, Demidov ON. Goloudina AR, et al. Cell Cycle. 2012 May 15;11(10):1883-7. doi: 10.4161/cc.19901. Epub 2012 May 15. Cell Cycle. 2012. PMID: 22544321 Free PMC article.

6

Wip1 phosphatase: between p53 and MAPK kinases pathways.

Goloudina AR, Kochetkova EY, Pospelova TV, Demidov ON. Goloudina AR, et al. Oncotarget. 2016 May 24;7(21):31563-71. doi: 10.18632/oncotarget.7325. Oncotarget. 2016. PMID: 26883196 Free PMC article. Review.

7

Wip1 inhibition leads to severe pro-inflammatory phenotype in skin in response to chemical irritation.

Grigorash BB, Uyanik B, Kochetkova EY, Goloudina AR, Demidov ON. Grigorash BB, et al. Among authors: goloudina ar. J Dermatol Sci. 2017 Jul;87(1):85-88. doi: 10.1016/j.jdermsci.2017.03.021. Epub 2017 Apr 1. J Dermatol Sci. 2017. PMID: 28404453 No abstract available.

8

Inhibition of HSP70: a challenging anti-cancer strategy.

Goloudina AR, Demidov ON, Garrido C. Goloudina AR, et al. Cancer Lett. 2012 Dec 28;325(2):117-24. doi: 10.1016/j.canlet.2012.06.003. Epub 2012 Jun 28. Cancer Lett. 2012. PMID: 22750096 Review.

9

Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis.

Demidov ON, Zhu Y, Kek C, Goloudina AR, Motoyama N, Bulavin DV. Demidov ON, et al. Among authors: goloudina ar. Cell Death Differ. 2012 Nov;19(11):1761-8. doi: 10.1038/cdd.2012.57. Epub 2012 May 4. Cell Death Differ. 2012. PMID: 22555459 Free PMC article.

10

HSP110 promotes colorectal cancer growth through STAT3 activation.

Berthenet K, Bokhari A, Lagrange A, Marcion G, Boudesco C, Causse S, De Thonel A, Svrcek M, Goloudina AR, Dumont S, Hammann A, Biard DS, Demidov ON, Seigneuric R, Duval A, Collura A, Jego G, Garrido C. Berthenet K, et al. Among authors: goloudina ar. Oncogene. 2017 Apr 20;36(16):2328-2336. doi: 10.1038/onc.2016.403. Epub 2016 Nov 7. Oncogene. 2017. PMID: 27819670

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters